Genmab — December 2024

[E_L]

@calliecoombsmd
Much lower severity CRS when using optimized schedule of epcoritamab and with promising response data - high rates of CR and uMRD! Median PFS 12.8 months. https://x.com/calliecoombsmd/status/1866254711781028086

[E_L]

and https://x.com/DrRaulCordoba/status/1866254668105707835

[E_L]

@OncLive
·
10 u
Epcoritamab monotherapy in patients aged >75 with DLBCL who were anthracycline ineligible resulted in ORR 69% (CR 62%) with durable responses. https://x.com/OncLive/status/1866261702074941460 https://x.com/Fer_martinmoro/status/1866262621726576992

[E_L]

a bit of a repeat - City of Hope Reports Novel Immunotherapy in Clinical Trial Shows Promise for Patients With Relapsed or Difficult to Treat Chronic Lymphocytic Leukemia (CLL) - https://www.businesswire.com/news/home/20241208552895/en/City-of-Hope-Reports-Novel-Immunotherapy-in-Clinical-Trial-Shows-Promise-for-Patients-With-Relapsed-or-Difficult-to-Treat-Chronic-Lymphocytic-Leukemia-CLL

[ProinvestorNEWS]

Genmab leverer igen lovende data fra kræfthåb https://proinvestor.com/investornyt/1251772/genmab-leverer-igen-lovende-data-fra-kraefthab

[lahn1]

Tak til EL for alle nyhederne. Noget har ændret sig i aktien, gode nyheder uden fald !

[KWC]

Lidt nyt fra konkurrenterne...

[KWC]

https://www.biospace.com/drug-development/gsk-touts-42-survival-benefit-for-blenrep-in-multiple-myeloma-strengthening-bid-for-market-return?_gl=1*10oq5ns*_up*MQ.._gaMzc1NzEzMDI4LjE3MzM4NDI3NDA._ga_Q90M6MWJZ4MTczMzg0MjczOC4xLjAuMTczMzg0MjczOC4wLjAuMA..

[KWC]

Gilead/Arcellx’s Anito-Cel’s Differentiated Safety Profile Challenges J&J/Legend’s Carvykti

Anito-cel has shown no signs of delayed neurotoxicity at around 9 months of follow-up, hinting at a safety profile that could set it apart from J&J and Legend’s Carvykti.

BioSpace (www.biospace.com)

[E_L]

Evaluate Pharma forecast Darzalex 2025 $13.17bn https://x.com/NatRevDrugDisc/status/1866496363371941939

[nohope]

En eller anden snottet provinsbank stiger 50 % og GEN falder.

[lahn1]

Fristes til at sige at det var da lidt rart med konkurrence i MM

[deleted-user]

jeg bliver altid så glad når Nohope skriver herinde. Det minder mig om, at der er plads til alle bidrag.

[JKY_VH]

Ja lad endelig Jansen mærke et lille pust i nakken

[Raun]

Genmab falder
stort set altid ovenpå ASH

[E_L]

there is just too much news on the JNJ antibodies to post all , but let's pick 1 - Vincent Rajkumar
@VincentRK
Just out: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma https://x.com/VincentRK/status/1866205101595189678

[E_L]

I remember the scepticism on maintenance and even more on smoldering therapie being debated here. maintenance is now common really and smoldering to come. we'll still benefit from it

[E_L]

Just a moment...

(www.nejm.org)

[lahn1]

If I am not wrong Rajkumar use to be sceptic on Dara in general. Nice to see him turn.

[bongobob]

1. Nov 2019 solgte jeg 1 aktie til kurs 1600, købte en flaske whisky og gav resten til Helge. Det bliver ikke gentaget, men det er vel en festdag med After ASH ?